Introduction
The hereditary periodic fever syndromes are a relatively recently recognized group of inherited inflammatory disSummary orders that are characterized by episodic, self-limited bouts of fever accompanied by unexplained arthritis, Familial Mediterranean fever (FMF) is a recessively inherited disorder characterized by dramatic episodes sterile peritonitis, pleurisy, and/or skin rash (reviewed in Kastner, 1996) . To date, three clinical diseases have of fever and serosal inflammation. This report describes the cloning of the gene likely to cause FMF been identified in this class: the recessively inherited familial Mediterranean fever (FMF, MIM249100) and from a 115-kb candidate interval on chromosome 16p. Three different missense mutations were identified in Dutch type periodic fever (MIM260920, also known as the hyperimmunoglobulinemia D syndrome), and the affected individuals, but not in normals. Haplotype and mutational analyses disclosed ancestral relationships dominantly inherited familial Hibernian fever (MIM142680). In addition, there are a number of other related but among carrier chromosomes in populations that have been separated for centuries. The novel gene encodes clinically distinguishable conditions (Gertz et al., 1987; Karenko et al., 1992 ) that have been described in case a 3.7-kb transcript that is almost exclusively expressed in granulocytes. The predicted protein, pyrin, is a reports but have not yet been organized into specific nosologic entities. member of a family of nuclear factors homologous to the Ro52 autoantigen. The cloning of the FMF gene
Of the three well-defined hereditary periodic fever syndromes, FMF is by far the most common and has promises to shed light on the regulation of acute inflammatory responses.
attracted the most investigative interest. FMF is seen *The International FMF Consortium is 7 Departments of Pediatrics and Medical comprised of the following groups: Genetics Group 1:
Cedars-Sinai Medical Center Ivona Aksentijevich, 1 † Michael Centola, primarily in individuals of non-Ashkenazi Jewish, Armeet al., 1995) were found to be unstable. We therefore established a highly redundant contig comprised of nian, Arab, and Turkish background. In these populations, the carrier frequency has been estimated to be small-insert YACs, P1s, PACs, BACs, and cosmids that completely spans the interval . Using as high as 1:5 (Rogers et al., 1989; Daniels et al., 1995; Yuval et al., 1995) , raising speculation that heterozyan independent panel of non-Ashkenazi Jewish families and newly developed microsatellites from Gé né thon, the gotes may have some selective advantage, perhaps manifested by increased resistance to an as yet uniden- French FMF Consortium (1996) identified markers ‫006ف‬ kb apart defining the MEFV interval by intrafamilial retified infectious agent. Depending on poorly defined hereditary and environmental factors (Pras et al., 1982) , combinants. By comparing FMF carrier chromosomes in their panel with the ancestral haplotype noted above, homozygotes often develop progressive systemic amyloidosis from the deposition of the acute phase reactant the French Consortium found "historical recombinants" that further narrowed the candidate interval to a ‫052ف‬ serum amyloid A (SAA). Prior to prophylactic treatment with colchicine, FMF amyloidosis was a significant kb YAC. Our own data defined a 285 kb candidate interval by observed intrafamilial recombinants and an ‫002ف‬ cause of renal failure and death in the Middle East. In the absence of an accurate diagnostic test, FMF patients kb minimal region by historical recombinants . Both of these sets of data are consistent in in countries where the disease is less prevalent often experience years of attacks and several exploratory surtheir placement of the FMF gene. We now report the cloning of the FMF gene from geries before the correct diagnosis is made and adequate treatment with colchicine is begun.
this 200 kb interval. Our strategy involved developing a detailed transcript map from this region by a combina-FMF attacks are characterized by a massive influx of polymorphonuclear leukocytes (PMNs) into the affected tion of exon amplification, direct cDNA selection, singlepass sequencing of a minimal tiling path of cosmids, anatomic compartment. Inciting factors are unclear, and, even off treatment, patients can sometimes inexpliand, for selected areas, finished sequencing. During the construction of the transcript map, we identified new cably go for long periods without symptoms, only to relapse into a frequent pattern of attacks at some later microsatellites that permitted further refinement of the candidate interval to the centromeric-most 115 kb. Ustime. At the biochemical level, patients have variously been reported to have abnormal levels of a C5a inhibitor ing two trapped exons as probes, we isolated a 3.7 kb clone from a leukocyte cDNA library. The protein prod- (Matzner and Brzezinski, 1984) , neutrophil-stimulatory dihydroxy fatty acids (Aisen et al., 1985) , and dopamine uct is predicted to be 781 amino acids in length and is a member of a family of proteins that includes the Ro52 ␤-hydroxylase (Barakat et al., 1988) , but none of these findings has led to the identification of the genetic basis autoantigen (Itoh et al., 1991) and RFP (ret finger protein, the gene encoded by the 5Ј half of the hybrid ret transof FMF.
In the absence of other functional clues, we undertook forming gene; Takahashi et al., 1988) . We have identified three missense mutations in the cloned cDNA, all of a positional cloning approach to identify the FMF gene (designated MEFV). Initial linkage studies placed MEFV which encode changes in the same highly conserved C-terminal domain. None of the three mutations is preson chromosome 16p (Pras et al., 1992) in a panel of nonAshkenazi Jewish families. Linkage to this region has ent in any of a large panel of normal control chromosomes. Two of these mutations are found on FMF carrier subsequently been confirmed and extended to all four major affected ethnic groups (Shohat et al., 1992; chromosomes in populations that, in some cases, have been geographically separated for over 2000 years, indiet al., 1994 French FMF Consortium, 1996) , although differences in severity among subpopulations has sugcating that most cases of FMF are descended from a very ancient pool of founders, and suggesting common gested the possibility of allelic heterogeneity . Early studies demonstrated a substantial founder origins for several Middle Eastern populations. effect in the Moroccan Jewish population (Aksentijevich et al., 1993) , and as markers closer to MEFV have been Results identified, it has become apparent that a high percentage of all North African Jewish FMF carrier chromoPositional Cloning Strategy somes (93% in our hands) are descended from a com- Figure 1 depicts schematically the recent steps in our mon ancestor (French FMF Consortium, 1996 ; Levy et positional cloning strategy. Based on early genetic localal., 1996; Balow et al., 1997) . This same ancestral haploization data, we established a contig spanning the 1 Mb type was observed in one third of the Armenian carrier interval between D16S94 and D16S2622 (Sood et al., chromosomes we have studied and in about 15% of 1997). Microsatellite markers from this interval defined Iraqi Jewish FMF chromosomes. a critical region of 285 kb (D16S468-D16S3376) based Using publicly available polymorphic markers, we naron observed recombinations in a panel of 61 families, rowed the candidate region to an approximately 1 Mb and a smaller candidate interval of ‫002ف‬ kb (D16S3082-interval lying between the polycystic kidney disease D16S3373) based on historical recombinants. Tran-(PKD1) and tuberous sclerosis (TSC2) genes on the teloscripts were then identified by a combined strategy of meric end, and the CREB-binding protein (CREBBP) exon amplification, direct cDNA selection, and singlegene on the centromeric end (Sood et al., 1996 ; see pass sequencing. This led to the isolation of 9 full-length Figure 1 ). The extensive physical maps constructed cDNA clones (8 of which were previously uncharacteraround these genes (Dackowski et al., 1996; Giles et al., ized) , including 3 classical zinc finger genes, 2 members 1997) did not, however, extend into the MEFV region, and large insert YACs mapping to this interval (Doggett of the olfactory receptor family, and a novel caspase. (A) ‫1ف‬ Mb region over which a cosmid contig was constructed . PKD1, polycystic kidney disease 1; TSC2, tuberous sclerosis 2; RSTS, Rubinstein-Taybi syndrome; CREBBP, CREB binding protein gene.
(B) ‫582ف‬ kb candidate interval defined by intrafamilial recombination events in our panel of families . D16S3405-D16S3373 is the minimal candidate interval defined by historical recombinants in the present study.
(C) Representation of the genomic structure of the v75-1 gene. Shaded boxes represent exons; introns are drawn to scale. Numbers above the boxes represent the size of the exons, in bp. Numbers below the boxes reflect the order of the exons, with (1) being the most 5Ј.
The furthest centromeric of these 9 cDNAs, clone v75-1, interferon-inducible transcriptional regulator Staf-50 (Tissot and Mechti, 1995) , and rpt-1, a mouse downwas isolated by solution hybridization of a leukocyte cDNA library with biotinylated oligonucleotide probes regulator of IL-2 (Patarca et al., 1988) . Homology to the latter protein is in a domain extending from residues derived from two exons trapped from PAC 273L24.
In parallel, analyzing finished sequence from ‫09ف‬ kb 385 to 550, while homology to the former two proteins is particularly high through a domain at the C-terminal in the center of the D16S3082-D16S3373 interval, we found two new microsatellites, D16S3404 and D16S3405 end of v75-1 (double-boxed in Figure 2 ). This domain is also found in the ret finger protein (RFP) and has been ( Figure 1B ). In one non-Ashkenazi Jewish family, evidence for a historical recombination event that occurred termed an rfp (Takahashi et al., 1988) or B30.2 domain (Vernet et al., 1993; Henry et al., 1997) . Analysis with the between D16S3404 and D16S3405 in the highly conserved non-Ashkenazi Jewish haplotype (designated SEG algorithm (Wootton, 1994 ) indicated a high likelihood that this domain assumes a globular conformation. haplotype A) was observed, thereby excluding the region telomeric of D16S3405 (and four candidate genes Additional analyses of the putative protein product, termed pyrin to connote its relationship to fever, indicate encoded therein) from further consideration.
that it is very positively charged, with a predicted pI Ͼ 8 and with lysine and arginine making up 13% of the Characterization of cDNA v75-1 The translated v75-1 cDNA sequence is shown in Figure  amino acid composition. Moreover, the PSORT algorithm (Nakai and Kanehisa, 1992) detected two overlap-2, and the exon-intron structure deduced from the genomic sequence of two cosmids is depicted in Figure 1C .
ping nuclear targeting signals. The first is a four-residue pattern composed of a histidine and three lysines (startAlthough there is an excellent Kozak consensus (Kozak, 1996) at the initial methionine, the reading frame remains ing at residue 419), and the second is a Robbins/Dingwall consensus (boxed in Figure 2 , residues 420-437; open in the cDNA upstream of this. Nevertheless, there are no splice-acceptor consensus sequences or in- Robbins et al., 1991) . In addition, a PROSITE search (Bairoch et al., 1997) identified a bZIP transcription facframe methionines with good Kozak sequences before the first stop upstream in genomic DNA, and the trantor basic domain (Shuman et al., 1990) at residues 266-280. The region between residues 375 and 407 (denoted script size by Northern blot (see below) is 3.7 kb, thus suggesting that the sequence presented is full-length.
by plus signs in Figure 2 ) contains an arrangement of cystine and histidine residues with spacing that conConsistent with the initial analysis of single-pass genomic sequence from this region, BLASTX (Altschul et forms closely to a B box-type zinc finger domain (Reddy et al., 1992 (Reddy et al., ). al., 1990 ) demonstrated homologies with a number of molecules implicated in inflammation. These include the Northern analysis using a probe with unique sequence from exon 2 of v75-1 showed an abundant ‫7.3ف‬ kb 52 kDa Ro/SS-A ribonucleoprotein, against which patients with systemic lupus erythematosus (SLE) and Sjö -transcript in peripheral blood, but there was no significant expression in 14 other normal tissues, including gren's syndrome frequently make autoantibodies, the The boxed segment from aa 266 to 280 is a bZIP transcription factor basic domain; the boxed segment from aa 420 to 437 is a Robbins/ Dingwall consensus nuclear targeting signal. The segment indicated by plus signs between residues 375 and 407 is a potential B-box zinc finger domain. The region double-boxed from residue 577 to 757 is a rfp, or B30.2, domain. Within this box, the three mutated amino acids are double-underlined. spleen and thymus ( Figure 3A ). Bone marrow and lymph 2080 causing a substitution of valine for methionine (M694V), was observed in a large number of affected nodes were also negative for v75-1 expression (data not shown). Among a panel of tumor cells, only the SW480 individuals bearing four apparently distinct diseaseassociated haplotypes (see below). The third, a T→C colorectal adenocarcinoma cell line showed significant expression. Expression of v75-1 was absent in HL-60 transition at nt 2177, results in the substitution of alanine for valine (V726A) and was observed in affected individupromyelocytic leukemia, K-562 erythroleukemia, and Burkitt's lymphoma. Even by RT-PCR, message was als bearing the C haplotype in a Druze family and in other FMF patients and carriers bearing this haplotype. not detectable in a peritoneal fibroblast cell line, or in fetal or adult brain (data not shown). Figure 3B demonWhen the remaining nine exons of v75-1 were sequenced in these haplotypes, no additional mutations strates pyrin expression in PMNs, but not in lymphocytes. We also found that pyrin is not expressed in were identified. monocytes purified from peripheral blood (data not shown).
Ancestral Relationships Among FMF Carrier Haplotypes Table 1 explores the relationship of v75-1 mutations with Mutational Analyses Direct sequencing of RT-PCR products or amplified exspecific disease-associated haplotypes in our study population. Haplotype A is the disease-associated hapons from the eight cDNAs telomeric to v75-1 failed to identify disease-associated mutations. In contrast, three lotype observed in a very high percentage of North African Jewish carrier chromosomes, but that is seen less different missense mutations were identified in exon 10 of v75-1 (Figure 4 ) after screening a total of 165 individufrequently in the Armenian and Iraqi Jewish populations. Haplotypes F and G are additional North African Jewish als from 65 families. The first mutation, a G→C transversion at nt 2040 that results in the substitution of isoleudisease-associated haplotypes, each observed in a single family, that appear by microsatellite analysis to be cine for methionine (M680I), was observed in the homozygous state in the affected offspring of a single different from the A haplotype (Table 1A) . Haplotype B is yet another distinct FMF haplotype observed in the Armenian family. The second, an A→G transition at nt Iraqi Jewish population, while the C haplotype is seen For any given haplotype, only one mutation was presin patients from several different ethnic groups. The J ent. Altogether, these three mutations accounted for 78 and K haplotypes have only been observed in Armenian carrier chromosomes in our panel. There were several affected individuals. Table 1A indicates no easily disother carrier chromosomes with different microsatellite cernible relationship among these haplotypes at the haplotypes for which we did not observe any of these level of microsatellites, except that haplotypes J and K three mutations (these latter carrier chromosomes have are identical in the region from D16S3403 to D16S2617. thus far only been screened for exon 10 mutations). In Table 1B summarizes data on 11 single nucleotide four separate families we have observed M694V/V726A polymorphisms (SNPs) that we have identified from compound heterozygotes. In one such family, the parwithin the v75-1 gene for each of the haplotypes defined ents are of Ashkenazi and Iraqi Jewish ancestry, with in Table 1A . Nine of these polymorphisms represent the Ashkenazi father carrying the V726A mutation on synonymous substitutions within exons of this gene, the C haplotype FMF chromosome. This haplotype eswhile the remaining two are seen in introns 4 and 6. The tablishes an ancestral link between Ashkenazi Jews, A, F, and G haplotypes are identical at all 11 polymorwho have lived in Eastern Europe for the last 1500 years, phisms, and, although the B haplotype differs from A, F, and the Druze, who have lived in isolated communities and G at the 5Ј end of the gene, SNPs for all 4 haplotypes in what is now Israel and Lebanon for the last ‫0001ف‬ converge beginning at exon 3. Similarly, SNPs for the years. The only other Ashkenazi Jewish carrier whom C, J, and K haplotypes also converge by exon 3. The we have genotyped also has the V726A mutation. "AFGB" and "CJK" core SNP haplotypes from exon 3
The M680I, M694V, and V726A mutations were not to 10 were also observed on significant numbers of present on any of 105 normal chromosomes in our study ethnically matched normal chromosomes (not shown).
population (defined by haplotype analysis in well-char- Table 1C , which correlates haplotypes with v75-1 muacterized families), nor in almost 200 North American tations, suggests that ancestral relationships among control chromosomes. It is also noteworthy that althese subsets of chromosomes are likely. Thus, the conthough no A haplotype-bearing noncarrier chromovergent A, F, G, and B haplotypes all bear the M694V somes could be identified, two noncarrier chromosomes mutation, while we have not observed M694V on haplowith the B haplotype (both by microsatellites and SNPs) types that do not share the AFGB core SNPs. Similarly, did not have the M694V mutation, further strengthening Armenian haplotypes J and K converge within v75-1 and the connection between the presence of the mutation both bear the same M680I mutation, while this mutation and disease. Moreover, 42% of a panel of 24 Middle has not been observed on haplotypes that do not have Eastern normal chromosomes bear the AFGB SNP core the CJK core SNPs. The C haplotype bears the same haplotype but do not carry M694V, which is further eviconvergent SNP haplotype as J and K, suggesting an dence that M694V is disease-causing, and not a private independent mutational event on an ancestral CJK-type chromosome.
polymorphism.
observation of normal chromosomes that bear diseaseassociated microsatellite and SNP haplotypes but do not have the M680I, M694V, or V726A mutations is strong evidence that these are not just haplotype-specific polymorphisms. While these genetic arguments firmly establish the identity of v75-1 as the FMF gene, data on v75-1 tissue distribution are highly consistent with the clinical phenotype. Based on the nature of the inflammatory infiltrate and the anatomic localization of inflammation in FMF, MEFV gene expression might be predicted to be observed in granulocytes and/or serosal cells. Multipletissue Northern blots demonstrated high levels of expression in peripheral blood leukocytes, but not in lymph node, spleen, or thymus, which are comprised largely of lymphocytes. From this we deduced that pyrin is most likely expressed primarily in mature granulocytes, an inference that was subsequently confirmed by direct observation.
Computational analyses of wild-type and mutant pyrin molecules suggest a mechanism by which the mutations identified may cause disease. All three mutations are clustered within 46 amino acids of one another in the highly conserved B30.2 (rfp) globular domain at the Given that FMF is a disease of excessive inflammation, for the mutation is shown as a closed red symbol. The control for and that pyrin is homologous to rpt-1, a known downthe M680I mutation is individual 76-06, the control for M694V is 76-regulator of inflammation, pyrin may be a negative auto-02, and the control for V726A is 3-01.
regulatory molecule in PMNs. The FMF-associated mutations and resultant pyrin structural changes would then, after some undefined event that triggers inflammaDiscussion tion, prevent the normal pyrin-mediated negative feedback loop. In this paper, we describe the molecular cloning of a None of these three mutations results in a truncated new cDNA, v75-1, from the familial Mediterranean fever protein, and the periodic nature of inflammatory attacks candidate region on chromosome 16p13.3 and present in FMF is consistent with a protein that functions adecompelling evidence that this gene is MEFV, the gene quately at steady state but decompensates under causing FMF. The cornerstone of the argument equating stress. Several other diseases with periodic manifestav75-1 with MEFV is the identification of three different tions follow this paradigm, including sickle cell anemia v75-1 mutations on FMF carrier chromosomes in multi-(␤-globin; Weatherall et al., 1995) and hyperkalemic periple ethnic groups, mutations that are not seen in a panel odic paralysis (adult skeletal muscle sodium channel; of almost 300 normal control chromosomes.
Ptá cek et al., 1991). Both are characterized by missense It is extremely unlikely that the substitutions we have mutations encoding an abnormal protein with reduced identified in v75-1 are actually polymorphisms in tight function. Patients experience symptoms when environlinkage disequilibrium with "real" mutations on a nearby mental factors (hypoxia or acidosis in the case of sickle gene. This hypothesis would require that there be three cell, excess consumption of potassium in periodic paralsuch v75-1 polymorphisms on three different haploysis) induce additional conformational changes in the types, each in perfect linkage disequilibrium with the protein (sickle cell) or destabilize a delicate equilibrium mutations on the real FMF gene. While not impossible, (periodic paralysis). Similarly, environmental triggers such a scenario is at the least unnecessarily complex.
may play a role in FMF, and the identification of pyrin It is also unclear where such a closely linked gene would should provide clues regarding the proximal steps in be located. The historical recombinants at the 5Ј (centrothe cascade that leads to an attack. meric) end of v75-1 exclude the interval between Just as protein-truncating mutations in globin pro-D16S3373 and v75-1. On the telomeric side, the 5Ј end duce thalassemia and not sickle cell disease, more proof a novel zinc finger gene is located within 10 kb of the found loss-of-function mutations in pyrin may produce 3Ј end of v75-1, but thorough screening has revealed no a phenotype much different from FMF. It is even conceivmutations in this latter gene (data not shown). Moreover, able that the total lack of pyrin may lead to generalized, there are no trapped exons, direct-selected cDNAs, or uncontrolled inflammation and may therefore be embryexpressed sequence tag (EST) hits that map to the interonically lethal. Mouse models may shed light on these questions. val between them. Finally, and most importantly, the Denotes the presence of a null allele with standard D16S2617 primers, but 107 bp amplicon when an alternative primer pair is used (Balow et al., in press ). d Designated by exon or intron; ϫ2.1 indicates the first polymorphism in exon 2. Below each designation is the nucleotide position in the sequence, with 1 being the adenosine in the ATG initiation codon. Note that the polymorphisms are listed 5Ј to 3Ј, from left to right, which is the opposite orientation on the chromosome from that shown in (A). It would appear that at least some of the phenotypic role of pyrin in the homeostatic control of inflammation is consistent with heterozygotes exhibiting heightened variation in FMF may be attributable to the difference between the M694V and V726A mutations. The M694V responses to a specific pathogen or class of pathogens. The strikingly high gene frequencies for FMF in more mutation is very common in the populations with the highest incidence of systemic amyloidosis (especially than one Middle Eastern population could then be explained by increased heterozygote resistance to such North African Jews), while V726A is seen in populations in which amyloid is less common (Iraqi and Ashkenazi an organism. Since the gene frequency for FMF is much lower in the East European Ashkenazi Jewish population Jews, Druze, and Armenians). Nevertheless, M694V-associated haplotypes can comprise a significant mi- (Yuval et al., 1995) , it is possible that such a selective factor would have been endemic to the Mediterranean nority of carrier chromosomes in populations where severe amyloidosis is exceedingly rare. One possible basin. The identification of pyrin should lead to testable hypotheses regarding the host inflammatory response explanation could be that the "milder" V726A mutation is "protective" against amyloid, in which case M694V/ in FMF heterozygotes. Our data indicate that the M694V and V726A muta-M694V homozygotes would be amyloid-prone but V726A homozygotes and compound heterozygotes tions are very old. Based on the convergence of several carrier haplotypes, it is likely that all modern M694V would not.
Although founder effects clearly have played a role in chromosomes are descended from a common founder. This mutation is seen on the B FMF haplotype commonly the population genetics of FMF, selection for heterozygotes remains an attractive hypothesis. The probable observed in Iraqi Jews, a group that remained relatively Sequences shown have statistical similarity as assessed by BLAST (Altschul et al., 1990) . Search cutoffs used to identify homologs were a Karlin-Altschul score of two aligned sequences у 70 with a probability р 10
Ϫ3
. At each position, residues occurring in a majority of the sequences are shown in inverse type. The numbering scheme at the top of the figure is based on the sequence of pyrin. The positions of secondary structural elements in the wild-type pyrin (here, all ␤ sheets) as predicted by the profile neural network method PHDsec Sander, 1993, 1994) are shown as bold, horizontal arrows below the alignment. The residues altered in the three mutants are indicated by downward-pointed arrowheads above the alignment. hum-RFP, RET finger protein (SWISS-PROT P14373); xla-xnf7, nuclear phosphoprotein xnf7, Xenopus laevis (PIR A43906); pwa-A33, zinc-binding protein A33, Pleurodeles waltl (SWISS-PROT Q02084); hum-SS-A/Ro, 52 kDa RO protein (SWISS-PROT P19474); hum-afp, acid finger protein (GenBank U09825); hum-BT, butyrophilin (GenBank U90552); hum-efp, estrogen-responsive finger protein (PIR A49656); hum-B30-2, B30-2 gene, (PRF 2002339); pig-RFB30, ring finger protein RFB30, Sus scrofa (EMBL Z97403); hum-Staf-50, transcription regulator Staf-50 (PIR A57041).
isolated from the rest of the Jewish population from the between these two structural elements is also highly conserved, suggesting that precise orientation of the time of the Babylonian captivity ‫0052ف(‬ years ago) until the formation of the state of Israel. Similarly, the obsertwo domains with respect to one another is required for function. The conservation of the rfp domain ( Figure 5 ) vation of the V726A mutation and C microsatellite haplotype in Armenians, Ashkenazi Jews, and Druze FMF in molecules as diverse as butyrophilin (a milk protein with probable receptor function; Jack and Mather, 1990 ), patients establishes a historical lower boundary on the age of this mutation of perhaps 2000 years.
Ro52 (a ribonucleoprotein that is autoantigenic in patients with SLE and Sjö gren's syndrome), A33 (a factor It is also possible, of course, that the M694V mutation, and its surrounding SNPs, has been transferred to four that binds polytene chromosomes in the newt; Bellini et al., 1993) , and xnf7 (a factor that binds mitotic chromodifferent haplotypes by interchromosomal gene conversion rather than by meiotic recombination events. In that somes in the frog; Reddy et al., 1991 ) is remarkable; the sequence identity among these proteins ranges from case, the estimation of the age of the original founder mutation would not be possible. Finally, the possibility 40% to 60%. Scrutiny of B30.2 mutations in pyrin may provide insights into this evolutionarily conserved but of multiple independent origins of M694V and M680I cannot be formally excluded, but the concordance of poorly understood domain. The identification of pyrin mutations as the cause of the SNP haplotypes close to the mutation (Table 1B and 1C) renders this possibility rather unlikely.
FMF will substantially advance our understanding of this disorder and will provide a tool to address questions The identification of pyrin as the molecule responsible for FMF also focuses interest on the RoRet family of ranging from population genetics to structural biology. It represents the first step in the delineation of an imporproteins, all of which share a B-box zinc finger as well as a 170 amino acid rfp (B30.2) domain. The spacing tant new pathway in the control of inflammation. .
rial. PCR screening of Superscript cDNA libraries (Life Technologies, One additional Ashkenazi/Iraqi Jewish family was also studied. The Gaithersburg, MD) derived from human brain, liver, leukocytes, diagnosis of FMF in all families was according to established clinical spleen, and testis were used to determine the tissue-specific excriteria (Sohar et al., 1967) . Patient consent was obtained from partipression of these exons. The leukocyte cDNA library was used in cipants in the study after approval by the human experimentation further experiments since it showed significant expression of v66 committees at each institution. DNA was extracted from whole blood and v75 exons. GeneTrapper experiments were performed with or from Epstein-Barr virus-transformed lymphocytes by standard sense and antisense primers from both exons, assuming both orientechniques.
tations of these exons in the putative transcript. The following oligonucleotides were synthesized and PAGE-purified: v66GT1: AAG CTC ACT GCC TTC TCC TC; v66GT2: GAG GAG AAG GCA GTG AGC Genotyping TT; v75GT1: GAC TTG GAA ACA AGT GGG AG; v75GT2: CTC CCA Patients were genotyped as previously described (Balow et al., CTT GTT TCC AAG TC. Oligos were biotinylated and hybridized to 1997). Additionally, genotyping by PCR was carried out with three single-stranded DNA from the leukocye cDNA library (one primer new markers that were developed in this study and are described per reaction), followed by cDNA capture using paramagnetic strephere (D16S3403, D16S3404, and D16S3405). Sequences of oligonutavidin beads and repair using the corresponding nonbiotinylated cleotides and PCR conditions used to amplify these markers are oligos. Colony hybridization of lifts using 32 P-dCTP end-labeled available from the Genome Database.
oligos was used to identify positive clones. Gel-purified inserts from these clones were hybridized to cosmid contig blots to distinguish Direct cDNA Selection cDNA clones mapping to the FMF region from false positive clones Cosmids, BAC, and P1 clones in the FMF candidate region were due to homologous domains. All positive clones were identified by biotinylated using BioPrime (Life Technologies, Gaithersburg, MD).
the primers v66GT2 and v75GT2, and no clones were identified by cDNAs were prepared from combined mRNA from fetal brain, fetal the other set of primers. liver, and human lymph node by reverse transcription and ligation of an EcoRI/NotI adaptor, which also served as a PCR primer, to
Oligonucleotides for Exon Amplification second-strand cDNAs. cDNAs were directly hybridized to biotinylOligonucleotides used to amplify pyrin exons were as follows (all ated templates that were recovered using streptavidin-labeled magoligo sequences are given 5Ј to 3Ј): exon 1 forward, AACCTGCCTTTT netic beads. Conditions for blocking, hybridization, binding, and CTTGCTCA; exon 1 reverse, CACTCAGCACTGGATGAGGA; exon 3 elution of cDNAs from magnetic beads (Dynal) were as described forward, GAACTCGCACATCTCAGGC; exon 3 reverse, AAGGCCCA (Parimoo et al., 1991) . After two rounds of selection, eluted cDNAs GTGTGTCCAAGTGC; exon 4 forward, TTGGCACCAGCTAAAGAT were amplified with CUA-tailed EcoRI/NotI adaptor primers and sub-GGC; exon 4 reverse, TCTCCCTCTACAGGGATGAGC; exon 5 forcloned into the pAMP10 vector (Life Technologies, Gaithersburg, ward, TATCGCCTCCTGCTCTGGAATC; exon 5 reverse, CACTGTGG MD) to yield libraries of selected cDNAs. Recombinant clones were GTCACCAAGACCAAG; exon 6 forward, TCCAGGAGCCCAGAAGTA arrayed on blots. Clones that hybridized to either repetitive or ribo-GAG; exon 6 reverse, TTCTCCCTATCAAATCCAGAG; exon 7 somal sequences were excluded from further analysis. To confirm forward, AGAATGTAGTTCATTTCCAGC; exon 7 reverse, CATTTCTG their origin, unique clones were individually hybridized to EcoRI AACGCAGGGTTT; exon 8/9 forward, ACCTAACTCCAGCTTCTCTC digests of cosmid/BAC/P1 DNAs and DNAs from chromosome 16-TGC; exon 8/9 reverse, AGTTCTTCTGGAACGTGGTAG; exon 10a specific human-hamster hybrid lines. Clones were then hybridized forward, CCAGAAGAACTACCCTGTCCC; exon 10a reverse, AGAGC to each other and were binned into groups. Representative clones AGCTGGCGAATGTAT; exon 10b forward, GAGGTGGAGGTTGGAG of each group were hybridized to multiple-tissue Northern blots and ACAA; exon 10b reverse, TCCTCCTCTGAAATCCATGG. sequenced.
Northern Blot Analysis Exon Trapping
To determine transcript size and level of expression in various tisExon trapping was performed on PAC clone 273L24 (Sood et al., sues, multiple-tissue Northern blots (Clontech) were hybridized with 1997) as previously described (Buckler et al., 1991) . PAC clone probes derived from various exons of the gene. These exons were 273L24 was partially digested with Sau 3AI. The reaction products amplified and purified as part of the sequencing protocol for mutawere size-fractionated by agarose gel electrophoresis, and DNA tion analysis. Larger exons (2, 5, and 10) were labeled by randomfragments 2 kb and larger were isolated from the gel. Partially dipriming using Stratagene Prime-It Kit and 32 P-dCTP (ICN). Hybridizagested DNA (50 ng) was ligated with 10 ng of exon-trapping vector tion and washing of blots were essentially as described in Sambrook pSPL3 that had been previously cleaved with BamHI and dephoset al. (1989) , except using Hybridisol I (Oncor) prepared hybridization phorylated with calf intestinal alkaline phosphatase (Promega, Madibuffer. Hybridization was detected by autoradiography, with 4 hour son, WI). Ligation products were electroporated into E. coli DH12B, exposures. Northern blots with mRNA from highly purified peripheral and the electroporated cells cultured en mass in LB broth with 200 blood lymphocytes, PMNs, and monocytes were the kind gift of Drs. mg/ml ampicillin for 16 hours at 37ЊC with shaking. DNA prepared H. Lee Tiffany and Harry Malech. from the culture was used to transfect COS-7 cells (ATCC 30-2002) using lipofectACE reagent (Life Technologies, Gaithersburg, MD). Total RNA was isolated from transfected COS-7 cells with Trizol
Mutation Detection by Fluorescent Sequencing
Approximately 100 ng of genomic DNA template was used in PCR reagent (Life Technologies) followed by ethanol precipitation. Firststrand cDNAs of transcription products from pSPL3 were primed reactions to amplify exons and flanking intronic sequences according to the supplier's recommendations for AmpliTaq Gold (Perwith the oligonucleotide SA2. Specific amplification of trapped exons was as follows: PCR primed with oligonucleotides SA2 and SD6 kin Elmer, Branchburg, NJ) and Advantage-GC Genomic PCR Kit (Clontech, Palo Alto, CA). The PCR primers were tailed with one of was performed, followed by digestion of the PCR products with BstXI. A second PCR reaction using the digestion products was the following sequences: -21M13 forward: GTAAAACGACGGC CAGT; -28 M13 reverse: CAGGAAACAGCTATGACCAT; -40 M13 forprimed with oligonucleotides dUSD2 and dUSA4. The resulting DNA fragments were cloned into pAMP10 vector and sequenced. Two ward: GTTTTCCCAGTCACGACG. After amplification, reactions were run on 1% agarose gels and gel-purified using either QIAquick hundred clones were sequenced and 20 independent exons were
